Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Clinical/translational cancer immunotherapy

Original research

Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors

Online download statistics by month:

Online download statistics by month: June 2021 to March 2024

	Abstract	Full	Pdf
Jun 2021	1191	1196	280
Jul 2021	36822	36826	93
Aug 2021	25430	25427	45
Sep 2021	15926	15926	37
Oct 2021	205	205	52
Nov 2021	155	154	47
Dec 2021	145	147	19
Jan 2022	104	107	29
Feb 2022	60	60	26
Mar 2022	66	66	20
Apr 2022	99	104	28
May 2022	127	130	54
Jun 2022	85	86	18
Jul 2022	89	103	33
Aug 2022	76	78	27
Sep 2022	70	77	28
Oct 2022	85	87	24
Nov 2022	51	51	16
Dec 2022	36	36	13
Jan 2023	41	41	17
Feb 2023	73	73	10
Mar 2023	63	65	28
Apr 2023	35	35	19
May 2023	32	33	9
Jun 2023	59	60	10
Jul 2023	54	55	24
Aug 2023	67	67	9
Sep 2023	138	139	24
Oct 2023	43	43	10
Nov 2023	85	85	10
Dec 2023	64	64	30
Jan 2024	58	63	99
Feb 2024	50	50	16
Mar 2024	57	57	40
Total	81741	81796	1244